Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease (2020)

Type of Content
Journal ArticlePublisher
Springer Science and Business Media LLCISSN
2041-1723Language
engCollections
- Science: Journal Articles [1104]
Authors
Abstract
An improved understanding of etiological mechanisms in Parkinson’s disease (PD) is urgently needed because the number of affected individuals is projected to increase rapidly as populations age. We present results from a blood-based methylome-wide association study of PD involving meta-analysis of 229 K CpG probes in 1,132 cases and 999 controls from two independent cohorts. We identify two previously unreported epigenome-wide significant associations with PD, including cg06690548 on chromosome 4. We demonstrate that cg06690548 hypermethylation in PD is associated with down-regulation of the SLC7A11 gene and show this is consistent with an environmental exposure, as opposed to medications or genetic factors with effects on DNA methylation or gene expression. These findings are notable because SLC7A11 codes for a cysteine-glutamate anti-porter regulating levels of the antioxidant glutathione, and it is a known target of the environmental neurotoxin β-methylamino-L-alanine (BMAA). Our study identifies the SLC7A11 gene as a plausible biological target in PD.
Citation
Vallerga CL, Zhang F, Fowdar J, McRae AF, Qi T, Nabais MF, Zhang Q, Kassam I, Henders AK, Wallace L, Montgomery G, Chuang YH, Horvath S, Ritz B, Halliday G, Hickie I, Kwok JB, Pearson J, Pitcher T, Kennedy M, Bentley SR, Silburn PA, Yang J, Wray NR, Lewis SJG, Anderson T, Dalrymple-Alford J, Mellick GD, Visscher PM, Gratten J (2020). Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nature Communications. 11(1). 1238-.This citation is automatically generated and may be unreliable. Use as a guide only.
Keywords
Chromosomes, Human, Pair 4; Humans; Parkinson Disease; Glutathione; Amino Acid Transport System y+; Case-Control Studies; DNA Methylation; Down-Regulation; CpG Islands; Adult; Aged; Aged, 80 and over; Middle Aged; Australia; New Zealand; Female; Male; Mendelian Randomization Analysis; Epigenomics; Healthy VolunteersANZSRC Fields of Research
31 - Biological sciences::3105 - Genetics::310509 - Genomics32 - Biomedical and clinical sciences::3209 - Neurosciences::320905 - Neurology and neuromuscular diseases
Rights
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/.Related items
Showing items related by title, author, creator and subject.
-
Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders
Nabais MF; Laws SM; Lin T; Vallerga CL; Armstrong NJ; Blair IP; Kwok JB; Mather KA; Mellick GD; Sachdev PS; Wallace L; Henders AK; Zwamborn RAJ; Hop PJ; Lunnon K; Pishva E; Roubroeks JAY; Soininen H; Tsolaki M; Mecocci P; Lovestone S; Kłoszewska I; Vellas B; Furlong S; Garton FC; Henderson RD; Mathers S; McCombe PA; Needham M; Ngo ST; Nicholson G; Pamphlett R; Rowe DB; Steyn FJ; Williams KL; Anderson TJ; Bentley SR; Fowder J; Gratten J; Halliday G; Hickie IB; Kennedy M; Lewis SJG; Montgomery GW; Pearson J; Pitcher TL; Silburn P; Zhang F; Visscher PM; Yang J; Stevenson AJ; Hillary RF; Marioni RE; Harris SE; Deary IJ; Jones AR; Shatunov A; Iacoangeli A; van Rheenen W; van den Berg LH; Shaw PJ; Shaw CE; Morrison KE; Al-Chalabi A; Veldink JH; Hannon E; Mill J; Wray NR; McRae AF; Dalrymple-Alford, John (Springer Science and Business Media LLC, 2021)Background: People with neurodegenerative disorders show diverse clinical syndromes, genetic heterogeneity, and distinct brain pathological changes, but studies report overlap between these features. DNA methylation (DNAm) ... -
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; Adarmes-Gómez AD; Aguilar M; Aitkulova A; Akhmetzhanov V; Alcalay RN; Alvarez I; Alvarez V; Barrero FJ; Bergareche Yarza JA; Bernal-Bernal I; Billingsley K; Blazquez M; Bonilla-Toribio M; Boungiorno MT; Brockmann K; Bubb V; Buiza-Rueda D; Cámara A; Carrillo F; Carrión-Claro M; Cerdan D; Chelban V; Clarimón J; Clarke C; Compta Y; Cookson MR; Craig DW; Danjou F; Diez-Fairen M; Dols-Icardo O; Duarte J; Duran R; Escamilla-Sevilla F; Escott-Price V; Ezquerra M; Feliz C; Fernández M; Fernández-Santiago R; Finkbeiner S; Foltynie T; Garcia C; García-Ruiz P; Gomez Heredia MJ; Gómez-Garre P; González MM; Gonzalez-Aramburu I; Guelfi S; Guerreiro R (Elsevier BV, 2019)Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope of biological knowledge about the disease over the past decade. We aimed to use the largest aggregate of GWAS data to ... -
Changes of plasma cGP/IGF-1 molar ratio with age is associated with cognitive status of Parkinson disease
Fan D; MacAskill M; Anderson T; Guan J; Dalrymple-Alford, John; Pitcher, Toni (Wiley, 2020)Objective: Cognitive impairment is a common feature of Parkinson disease (PD), for which age is a major contributing factor. Insulin-like growth factor-1 (IGF-1) declines with age and contributes to age-related cognitive ...